It seems that New Jerseyans will have to wait a bit longer to purchase recreational cannabis, as the state regulator for the nascent industry rejected the applications from eight medical cannabis operators — dubbed Alternative Treatment Centers and all owned by MSOs — to launch adult-use sales.
Curaleaf Holdings’ founder and chairman Boris Jordan was one of many disappointed cannabis entrepreneurs who did not take the news well.
“Frustrating day in NJ – once again, the goal posts have been moved & the will of the people and the Governor is being ignored! We will continue to fight for what the NJ voters decided they want – a safe & regulated adult-use cannabis marketplace,” Jordan said in a recent Tweet.
The New Jersey Cannabis Regulatory Commission took the decision on the grounds that, in the aggregate, cannabis operator in the state doesn’t have enough capacity to serve the current medical market.
Following its midday meeting, the state regulator called a special meeting for April 11, where the issue will be revisited.